Total Funding
25
50
Total FundingPost-IPO Equity raised
Growth Score
0 pts
Heat Score
3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
27296
Omega Therapeutics offers a proprietary epigenomic programming platform.
Acquired by 
Senda Biosciences
- Jennifer Nelson: SVP of Research
- Kaan Certel: Chief Business Officer
About the Company
Omega Therapeutics, Inc. is a development-stage biotechnology company leveraging its proprietary epigenomic programming platform to biologically engineer a new class of programmable epigenetic medicines.
